Cerebral Edema Management*
* based on interpretation of surrogate ICP waveform and derived parameters considering publications demonstrating derived parameter’s ability to assess risk of hypertension and progression of compliance.
Benefits
- Non-Invasive: a safe, quick, and patient-friendly approach for point-of-care monitoring
- Proactive: early warning data on changes to intracranial pressure (ICP)
- Individualized: personalized information to your non-invasive toolkit
- Wider window of opportunity: any time, anywhere
Ideal patient
Those at risk or under suspicion of cerebral edema.
Workflow
Baseline patient
- Durint admission, execute a 5–10-minute session after patient stabilization to define baseline.
- Record key patient data to support trend analysis.
Trend patient
- Repeat sessions every 4–6 hours and adjust frequency based on patient condition.
- Use continuous monitoring when evaluating therapeutic interventions or if higher parameter values (e.g., P2/P1 > 1.4, nTTP > 0.3) are observed.
Data interpretation*
- Higher median values: Elevated P2/P1 ratios and nTTP suggest higher risk of intracranial hypertension (IH)
- Lower median values: P2/P1 < 0.8 indicates a lower likelihood of IH
- Trends: Increasing P2/P1 and nTTP values may signal worsening compliance
